Gastric Cancer
Conditions
Interventions
Ninjin-Yoei-To 3.0g / time 3 times a day before meals. From the date of registration, the drug used will be administered daily according to the above usage.
Standard treatment without Ninjin-Yoei-T
Sponsors
Osaka Medical and Pharmaceutical College
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Adults between the ages of 20 and 80 at the time of registration. 2,Histologically diagnosed as adenocarcinoma by biopsy from the primary tumor of the stomach. 3. The diagnosis is stage IV, which cannot be completely resected by diagnostic imaging. 4. Patients who can receive chemotherapy with Performance Status (PS) 0-1. 5. Chemotherapy has not been performed at the time of registration. 6. Does not meet the diagnostic criteria for cachexia by European Palliative Care Research Collaborative (EPCRC). The diagnostic criteria are as follows. 1)Over 5% weight loss in the last 6 months 2)Patients with BMI <20 kg / m2 have more than 2% weight loss 3)Extremity skeletal muscle index (male 7.26 kg / m2, female <5.45 kg / m2) indicating sarcopenia, and any weight loss greater than 2% 7. It is possible to take medicine internally. 8. Consent has been obtained for participation in this study.
Exclusion criteria
Exclusion criteria: 1.Have active multiple cancers. 2. There is an active infectious disease. 3. Have clinically problematic diseases (collagen disease, renal failure, interstitial pneumonia, etc.) 4. It is judged that it is difficult to participate in the research because of mental illness or psychiatric symptoms. 5. In addition, the doctor in charge judges that it is inappropriate as the subject of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in time to onset of cachexia | — |
Countries
Japan
Contacts
Public ContactMasahiro Goto
Osaka Medical and Pharmaceutical College Cancer Chemotherapy Center
Outcome results
None listed